Cortifoam

Product manufactured by Meda Pharmaceuticals

Application Nr Approved Date Route Status External Links
NDA017351 None Topical None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Cortifoam ® Is Indicated As Adjunctive Therapy In The Topical Treatment Of Ulcerative Proctitis Of The Distal Portion Of The Rectum In Patients Who Cannot Retain Hydrocortisone Or Other Corticosteroid Enemas.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Hydrocortisone Acetate HYDROCORTISONE ACETATE ZINC13540519

Comments